Setanaxib
Setanaxib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against NADPH oxidase 4 and NADPH oxidase 1. In addition, it is known to target cytochrome b-245 heavy chain and NADPH oxidase 5.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
7 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Idiopathic pulmonary fibrosis | D054990 | J84.112 | — | 1 | — | — | — | 1 | |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Squamous cell carcinoma of head and neck | D000077195 | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | SETANAXIB |
INN | setanaxib |
Description | Setanaxib (development code GKT-831) is an experimental orally bioavailable dual inhibitor of NADPH oxidase isoforms NOX4 and NOX1. Setanaxib is a member of the pyrazolopyridine dione chemical series. The compound is the only specific NOX inhibitor that has entered into clinical trials.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1 |
Identifiers
PDB | — |
CAS-ID | 1218942-37-0 |
RxCUI | — |
ChEMBL ID | CHEMBL4303187 |
ChEBI ID | — |
PubChem CID | 58496428 |
DrugBank | — |
UNII ID | 45II35329V (ChemIDplus, GSRS) |
Target
Alternate
CYBB
CYBB
NOX5
NOX5
Organism
Homo sapiens
Gene name
CYBB
Gene synonyms
NOX2
NCBI Gene ID
Protein name
cytochrome b-245 heavy chain
Protein synonyms
CGD91-phox, Cytochrome b(558) subunit beta, cytochrome b-245 beta polypeptide, Cytochrome b558 subunit beta, gp91-1, gp91-phox, Heme-binding membrane glycoprotein gp91phox, NADPH oxidase 2, Neutrophil cytochrome b 91 kDa polypeptide, p22 phagocyte B-cytochrome, Superoxide-generating NADPH oxidase heavy chain subunit
Uniprot ID
Mouse ortholog
Cybb (13058)
cytochrome b-245 heavy chain (Q61093)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 110 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more